Sally Robinson Chair of the Animal Welfare and Ethical Review Body

Sally Robinson

Chair of the Animal Welfare and Ethical Review Body

Sally currently chairs the Animal Welfare and Ethical Review Body (AWERB) for Cancer Research UK Manchester Institute. In her role she has a number of responsibilities, which include advising on animal welfare and the 3Rs, as well as promoting a ‘culture of care’ within the Institute.

About Dr Sally Robinson

Dr Robinson completed her BSc and PhD in Chemistry and Pharmacology at the University of Liverpool.   

Sally worked at AstraZeneca for 26 years mainly within safety assessment.  From 2013 she was the Director ofthe Animal Sciences and Technology team (and the Establishment Licence Holder) supporting oncology in vivo research. She led an initiative to remove the requirement for acute toxicity studies from drug development leading to a revision of ICH M3 guidelines and received an international award for the enhancement of animal welfare for this work. She has over 30 publications relating to the application of the 3Rs and Culture of Care in animal research 

Sally has also recently completed a Master’s in Medical Ethics and Law.  She was a member of the Animals in Science committee from 2016-2023.  Currently, Sally chairs the AWERBs for Cancer Research UK Manchester Institute and the University of Bristol. 

Current affiliations include: 

  • UK NC3Rs Board member and Chair of UK NC3Rs studentship panel  
  • Secretary General Laboratory Animal Science Association (LASA)  
  • VP Institute of Animal Technology (IAT) President’s Advisory Group 

Why I work at CRUK MI

“Through my career at AstraZeneca, I have seen the impact that new medicines can have on the quality of life for many people. In my last few years at AstraZeneca, I headed up the animal facility and team that supported oncology research and during that time we shared the facility with CRUK MI. I am passionate about the role animal research has in developing our understanding of disease processes and CRUK MI is a natural fit after my career at AstraZeneca. It is fascinating to see the research that is being conducted at CRUK MI. The institute is a great place to work.”